Agreement worked out between insurers, manufacturers and administration.
More than 1,750 Medicare Part D drug plans and Medicare Advantage plans will cap the cost of insulin copays at $35 under a new agreement negotiated by President Trump’s administration with insurance companies and drug manufacturers.
The Centers for Medicare & Medicaid Services says enrollees in those plans will save an average of $446 per year. They also report that one in three seniors has diabetes.
Plans that cover the new benefit will be available in all 50 states, the District of Columbia and Puerto Rico with open enrollment beginning October 5 and ending December 7.
Kellyanne Conway, President Trump’s senior adviser, said, “The timing really is keyed toward open enrollment and is also just the latest step in what has been a three-plus-year effort to reduce prescription drug costs, including among vulnerable populations like seniors. So we’re talking prescription drugs today, not politics here at the White House.”
As the Lord Leads, Pray with Us…
- With thanksgiving for the successful negotiations made by the president’s administration for the lowering of insulin copays under Medicare.
- About the number of seniors who are dealing with diabetes.
- For President Trump and his further desire to reduce more prescription drug prices.
Sources: Newsmax, New York Times
